Search results
Thrombin (IIa), Human
Recommended for all research protocols where a source of highly purified and characterized (h)-thrombin is necessary, and for studies on anti-thrombin activities.
uPA (Urokinase Plasminogen activator)
Recommended for all research protocols where a source of purified urokinase is required. Can be used for the assay of human plasminogen. Activates plasminogen to generate plasmin.
Factor XIII Deficient Plasma
For any in vitro protocol or research study where a source of human FXIII deficient plasma is required.
vWF Deficient Plasma
For any in vitro protocol or research study where a source of vWF deficient plasma is required.
Protein C Deficient Plasma
For any in vitro protocol or research study where a source of human protein C deficient plasma is required.
Factor XII Deficient Plasma
Measurement of factor XII (FXII or factor hageman) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent).For any in vitro protocol or research study where a source of human FXII deficient plasma is required.
Factor XI Deficient Plasma
Measurement of factor XI (FXI or factor rosenthal) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FXI deficient plasma is required
Factor X Deficient Plasma
Measurement of factor X (FX or stuart factor) activity in human citrated plasma using a clotting method, triggered with calcium thromboplastin. For any in vitro protocol or research study where a source of human FX deficient plasma is required
Factor IX Deficient Plasma
Measurement of factor IX (FIX) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FIX deficient plasma is required.
Factor VIII Deficient Plasma
Measurement of actor VIII (FVIII) activity in human citrated plasma using a clotting method, in the presence of cephalin, activator and calcium (aPTT reagent). For any in vitro protocol or research study where a source of human FVIII deficient plasma is required.